StimScience is a technology company.
StimScience has raised $16.0M across 2 funding rounds.
StimScience has raised $16.0M in total across 2 funding rounds.
StimScience has raised $16.0M in total across 2 funding rounds.
StimScience's investors include Innovation Endeavors, Shane Neman, Thomas Tull, Yann LeCun, Alchemist Accelerator, CP Ventures, Monozukuri Ventures, Will Herman.
StimScience is a neuroscience-driven technology company that develops advanced consumer sleep technology, primarily through its flagship product, the Somnee Smart Sleep Headband. This clinical-grade device uses EEG brain mapping combined with AI-powered personalized closed-loop neurostimulation to improve sleep quality by supporting restorative sleep without requiring overnight wear. StimScience serves individuals seeking better sleep health, addressing the widespread problem of poor sleep quality that affects mental and physical well-being. The company has demonstrated strong growth momentum, raising over $10 million in funding by mid-2025 and earning multiple prestigious awards for innovation in sleep technology[1][3].
Founded in 2017 by UC Berkeley scientists Drs. Matthew Walker, Robert Knight, Rich Ivry, and Ram Gurumoorthy, StimScience emerged from decades of pioneering sleep research and neuroscience expertise. The idea originated from the founders’ deep understanding of sleep’s critical role in brain and body health, as popularized by Dr. Walker’s bestselling book *Why We Sleep*. Early traction included successful prototype development and clinical validation, culminating in the 2022 launch of the Somnee headband. The company expanded its patent portfolio significantly from 2020 onward, reflecting a strategic focus on personalized sleep intervention technologies and biomarker-driven sleep state modeling[1][3][4].
StimScience rides the growing trend of personalized health technology and consumer neuroscience, capitalizing on increasing awareness of sleep’s importance for overall health. The timing is favorable due to rising consumer demand for non-pharmaceutical, tech-enabled solutions to sleep disorders and the broader wellness market’s expansion. Market forces such as advances in wearable EEG technology, AI, and neurostimulation converge to enable StimScience’s innovative approach. The company influences the ecosystem by bridging rigorous neuroscience research with accessible consumer products, potentially setting new standards for sleep health interventions[1][3].
Looking ahead, StimScience is poised to expand its product line and deepen its AI personalization capabilities, potentially exploring applications beyond sleep, such as anesthesia monitoring and neurological therapies hinted at in their patents. Trends shaping their journey include growing digital health adoption, increasing investment in neurotechnology, and heightened consumer focus on mental health and wellness. As the company scales, its influence may extend into clinical and therapeutic domains, further integrating neuroscience with everyday health management[1]. StimScience’s trajectory exemplifies how cutting-edge science can translate into impactful consumer technology addressing a critical global health challenge.
StimScience has raised $16.0M across 2 funding rounds. Most recently, it raised $10.0M Seed in June 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 1, 2025 | $10.0M Seed | Innovation Endeavors, Shane Neman, Thomas Tull, Yann LeCun | |
| Mar 1, 2021 | $6.0M Seed | Alchemist Accelerator, CP Ventures, Monozukuri Ventures, Will Herman |